The problem with health AI today

AI is ready to transform metabolic health. The architecture is now ready.

Hormonal fluctuations across the lifespan significantly impact glucose tolerance, energy metabolism, and inflammatory markers. PCOS, gestational diabetes, Alzheimer’s, and perimenopause all share a common thread: insulin resistance and poor glucose control. Yet scalable infrastructure to deliver continuous, personalised metabolic guidance has never existed - until now.

Download the Executive Summary - and be first in line for the full paper.

The full whitepaper is coming soon. Download the executive summary now — and be the first to receive the full paper when it launches.

Expert knowledge defines the boundaries. AI operates freely within them.

Hello Inside has built and validated a two-layer Controlled-by-Design architecture that separates what is clinically safe from what is optimal for each individual. The Signal Intelligence Library — 100+ validated metabolic patterns refined over four years — cannot be shortcut by training larger models on larger datasets.

This is a platform in continuous production, validated across 12,000+ metabolic-behavioural profiles. Every recommendation traces to an explicit signal with clinical rationale. Unsafe outputs are structurally prevented — not reactively filtered.

  • 10K+

    Metabolic profiles validated

  • 250+

    signals in validated library

  • 4

    Years in continuous production

1 of 3
Why Architecture Is the Differentiator
Why Architecture Is the Differentiator

Challenge

LLM-Only Systems

Controlled-by-Design (Hello Inside)

Why It Matters

Safety

Post-hoc prompt filtering — outputs are reviewed after generation and blocked if flagged

✅ Structurally prevented by design — unsafe outputs cannot be generated at all

Regulators require structural prevention, not reactive filtering

Explainability

Black-box generation — no traceable reasoning path exists between input and advice

✅ Every recommendation traces to a validated signal with explicit clinical rationale

Mandatory for regulatory audit, clinical trust, and liability management

Personalisation

Generic population patterns — same intervention logic applied regardless of individual context

✅ Individual + population data, menstrual-cycle-aware, adapts to the whole metabolic picture

Behaviour change requires context-sensitivity — generic advice produces generic results

Scalability

Governance degrades under volume — manual review pipelines cannot scale to millions of interactions

✅ Safety scales with users, not headcount — the architecture carries the governance load

Millions of daily interactions without quality or compliance loss

*Based on internal benchmarking and published LLM health AI evaluation data. Full methodology in the white paper.

Inside the executive summary

What you'll find in the full report

  • 01

    The Opportunity Gap

    Why a decade of digital health apps failed to produce sustained behaviour change — and what the evidence says about what actually works.

  • 02

    The Controlled-by-Design Architecture

    A detailed breakdown of the two-layer system: Expert Knowledge as Constraint and AI as Personalisation Engine — how they interact and why the separation matters.

  • 03

    Production-Validated Outcomes

    Real-world data from 12,000+ metabolic-behavioural profiles. Clinically meaningful results in weight, energy, and symptom management — not concept-stage projections.

1 of 3
FAQs

When is the full paper coming out & why download the executive summary now?

The full Whitepaper is coming soon. Download the executive summary now to understand the architecture - you’ll receive the full paper directly when it launches.

What exactly is Controlled-by-Design AI — and how is it different from a regular LLM?

Most health AI systems layer a large language model on top of user data and hope guardrails catch unsafe outputs before they reach the user. Controlled-by-Design works the opposite way. A clinically validated Signal Intelligence Library — 250+ metabolic patterns encoded by experts — defines a constrained solution space upfront. The AI only ever operates within that space. It personalises timing, framing, and prioritisation freely, but it cannot generate a recommendation that falls outside clinically safe boundaries. Safety is structural, not reactive.

Why does this architecture matter specifically for women's health?

Women's health benchmarks expose a consistent weakness in LLM-only systems: failure rates approaching 60% on context-sensitive scenarios involving menstrual cycle phases, perimenopause, and hormonal fluctuations. These aren't edge cases — they're everyday realities for Hello Inside's users. The Signal Library includes explicit cycle-phase constraints (for example, no fasting advice during the luteal phase due to increased insulin sensitivity). This knowledge is encoded as a hard rule, not a soft prompt. No amount of fine-tuning alone produces that kind of structural reliability.

Is this white paper relevant to me if I'm not a clinician or AI researcher?

Yes. The executive summary is written for a mixed audience — including investors, health tech operators, digital health strategists, and informed general readers. It explains the core architecture problem in plain language before going into technical detail. If you're building, funding, or evaluating health AI products, the architecture argument matters directly to your work. If you're a Hello Inside user, it shows you exactly how the system that guides your daily insights was built — and why it's designed to be safe by default.

How is the Signal Intelligence Library built and kept up to date?

Expert-defined signal candidates are first validated in shadow mode — they run in the background across the user population without influencing outputs. Once they pass rigorous statistical and population testing, they graduate into the active library and immediately improve personalisation for all users. Each production cycle generates richer outcome data that feeds the next validation round. This flywheel has been running since 2021. It is the compounding knowledge asset at the centre of the architecture — and the part that cannot be replicated by training a larger model on a larger dataset.